Old Web
English
Sign In
Acemap
>
Paper
>
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
2011
Heleen D. de Koning
Joost Schalkwijk
Jos W. M. van der Meer
Anna Simon
Keywords:
Canakinumab
Cancer research
Schnitzler syndrome
Medicine
Mediator
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]